Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicki Brower

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Nature Biotechnology|January 1, 1997
Lawyers, physicians seek genomics rulesVicki Brower
Journal of the National Cancer Institute|March 24, 2012
New pain drugs in pipeline, but challenges to usage remainVicki Brower
Journal of the National Cancer Institute|July 9, 2011
Myeloma researchers gain genome, new targets, and new concernsVicki Brower
Journal of the National Cancer Institute|September 17, 2009
Drugs are scarce as mix of programs aims to ease accessVicki Brower
Journal of the National Cancer Institute|April 15, 2010
Telomerase-based therapies emerging slowlyVicki Brower
Journal of the National Cancer Institute|July 10, 2010
Clues emerge on how HIV increases lymphoma riskVicki Brower
Journal of the National Cancer Institute|July 9, 2009
Laparoscopic versus open surgery in cancer: new studies add data to debateVicki Brower
Journal of the National Cancer Institute|May 10, 2015
Programmed death protein 1 inhibitors making inroads in multiple cancersVicki Brower
The Lancet. Oncology|December 27, 2016
Onartuzumab ineffective in non-small-cell lung cancerVicki Brower
The Lancet. Oncology|January 17, 2017
Pioglitazone with imatinib in CML may reduce residual diseaseVicki Brower
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Nature Biotechnology|January 1, 1997
Lawyers, physicians seek genomics rulesVicki Brower
Journal of the National Cancer Institute|March 24, 2012
New pain drugs in pipeline, but challenges to usage remainVicki Brower
Journal of the National Cancer Institute|July 9, 2011
Myeloma researchers gain genome, new targets, and new concernsVicki Brower
Journal of the National Cancer Institute|September 17, 2009
Drugs are scarce as mix of programs aims to ease accessVicki Brower
Journal of the National Cancer Institute|April 15, 2010
Telomerase-based therapies emerging slowlyVicki Brower
Journal of the National Cancer Institute|July 10, 2010
Clues emerge on how HIV increases lymphoma riskVicki Brower
Journal of the National Cancer Institute|July 9, 2009
Laparoscopic versus open surgery in cancer: new studies add data to debateVicki Brower
Journal of the National Cancer Institute|May 10, 2015
Programmed death protein 1 inhibitors making inroads in multiple cancersVicki Brower
The Lancet. Oncology|December 27, 2016
Onartuzumab ineffective in non-small-cell lung cancerVicki Brower
The Lancet. Oncology|January 17, 2017
Pioglitazone with imatinib in CML may reduce residual diseaseVicki Brower
Pageof 18